World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00964938
Date of registration: 25/05/2009
Primary sponsor: St. Jude Medical
Public title: Multisite Pacing With a Quadripolar Lead
Scientific title: Multisite Pacing With a Quadripolar Left Heart Lead in Cardiovascular Resynchronization Therapy (CRT) Patients
Date of first enrolment: August 2009
Target sample size: 35
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00964938
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label  
Countries of recruitment
Canada
Contacts
Name:   B Thibault
Address: 
Telephone:
Email:
Affiliation:  Montreal Heart
Key inclusion & exclusion criteria

Inclusion Criteria:

- Have a scheduled CRT implantation at the participating clinical study site

- Have NYHA functional class III or IV, ejection fraction less than or equal to 35%,
and QRS duration greater than 120ms

- Be undergoing a new St. Jude Medical CRT-D device system (including LV lead)
implantation

- Have the ability to provide informed consent for study participation and be willing
and able to comply with the prescribed perioperative evaluations

Exclusion Criteria:

- Have persistent or permanent atrial fibrillation

- Have an intrinsic heart rate of <50 beats per minute

- Have a recent myocardial infarction within 40 days prior to enrollment

- Have undergone cardiac surgery or coronary revascularization procedure within 3
months prior to enrollment or be scheduled for such procedures

- Have had a recent CVA or TIA within 3 months prior to enrollment

- Have had intravenous inotropic support in the last 30 days

- Have ischemic etiology and are unable to tolerate stress echocardiography



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Heart Failure
Intervention(s)
Device: Quadripolar LV lead (pacing configurations)
Primary Outcome(s)
dP/dt max [Time Frame: acute: during implant procedure; 1 day]
Secondary Outcome(s)
Secondary ID(s)
MSLV
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history